Evaluation of hyaluronic acid as a pharmacologically active excipient for Gemcitabine in the treatment of pancreatic cancer

被引：0
|
作者：
Brown, Tracey J.
Falzon, Jeanette L.
Minh Pho
Thomas, Natalie
Brownlee, Gary
机构：
[1] Meditech Res Ltd, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Meditech Res, Melbourne, Vic, Australia
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3079
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid
    Correale, P
    Messinese, S
    Marsili, S
    Ceciarini, F
    Pozzessere, D
    Petrioli, R
    Sabatino, M
    Cerretani, D
    Pellegrini, M
    Di Palma, T
    Neri, A
    Calvanese, A
    Pinto, E
    Giorgi, G
    Francini, G
    BRITISH JOURNAL OF CANCER, 2003, 89 (02) : 239 - 242
  • [32] A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid
    P Correale
    S Messinese
    S Marsili
    F Ceciarini
    D Pozzessere
    R Petrioli
    M Sabatino
    D Cerretani
    M Pellegrini
    T Di Palma
    A Neri
    A Calvanese
    E Pinto
    G Giorgi
    G Francini
    British Journal of Cancer, 2003, 89 : 239 - 242
  • [33] In vivo evaluation of combination treatment with gemcitabine (dFdC) and tetrahydrouridine (THU) in xenograft models of pancreatic cancer
    Eiseman, Julie
    Bai, Lihua
    Liggett, Dana
    Egorin, Merrill
    Covey, Joseph
    Beumer, Jan
    CANCER RESEARCH, 2009, 69
  • [34] Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer
    Zhao, Ming
    Tominaga, Yohei
    Ohuchida, Kenoki
    Mizumoto, Kazuhiro
    Cui, Lin
    Kozono, Shingo
    Fujita, Hayato
    Maeyama, Ryo
    Toma, Hiroki
    Tanaka, Masao
    CANCER SCIENCE, 2012, 103 (01): : 58 - 66
  • [35] Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer
    Yanagimoto, Hiroaki
    Mine, Takashi
    Yamamoto, Koutaro
    Satoi, Sohei
    Terakawa, Naoyoshi
    Takahashi, Kanji
    Nakahara, Kimika
    Honma, Shigenori
    Tanaka, Masahiro
    Mizoguchi, Junko
    Yamada, Akira
    Oka, Masaaki
    Kamiyama, Yasuo
    Itoh, Kyogo
    Takai, Soichiro
    CANCER SCIENCE, 2007, 98 (04) : 605 - 611
  • [36] Can intracellular drug delivery using hyaluronic acid functionalised pH-sensitive liposomes overcome gemcitabine resistance in pancreatic cancer?
    Tang, Mingtan
    Svirskis, Darren
    Leung, Euphemia
    Kanamala, Manju
    Wang, Hongbo
    Wu, Zimei
    JOURNAL OF CONTROLLED RELEASE, 2019, 305 : 89 - 100
  • [37] Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer
    Monti, Daniel A.
    Mitchell, Edith
    Bazzan, Anthony J.
    Littman, Susan
    Zabrecky, George
    Yeo, Charles J.
    Pillai, Madhaven V.
    Newberg, Andrew B.
    Deshmukh, Sandeep
    Levine, Mark
    PLOS ONE, 2012, 7 (01):
  • [38] Active Systemic Treatment of Pancreatic Cancer
    Tempero, Margaret
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 723 - 725
  • [39] A novel way to sensitize pancreatic cancer cells for gemcitabine treatment
    Xie, Jingwu
    Gu, Dongsheng
    Zhang, Xiaoli
    Jia, Yanfei
    Chiorean, Gabi
    CANCER RESEARCH, 2016, 76
  • [40] The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation
    Mukubou, Hideyo
    Tsujimura, Toshiaki
    Sasaki, Ryohei
    Ku, Yonson
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 37 (04) : 821 - 828
12345